Editors' picks from other sources

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB transmission and prevention news

Show

From To
TB transmission and prevention
Major South African Trial Did Not Improve Tuberculosis Control in Gold Mines

A major trial aiming to cut the rate of tuberculosis among South Africa's gold miners did not reduce the number of cases or deaths from the disease, according to a study.

Published
27 January 2014
From
Science Daily
TB transmission and prevention
Tuberculosis in South Africa's Gold Mines; A United Call to Action

This report, co-authored by RESULTS UK and the AIDS and Rights Alliance for Southern Africa, seeks to summarise the epidemics of TB and silicosis and among Southern Africa’s gold miners; to detail civil society, governmental and other stakeholder campaigns and interventions to tackle the crises; and to present policy recommendations for donor and regional governments, CSOs and mining companies.

Published
28 November 2013
From
RESULTS
TB transmission and prevention
First results of tuberculosis vaccine candidate MTBVAC very promising

A phase I safety study of TB vaccine candidate MTBVAC, the first live-attenuated Mycobacterium  tuberculosis-based vaccine to enter clinical trials, shows very good results in the first intermediate analysis.

Published
18 November 2013
From
TuBerculosis Vaccine Initiative
TB transmission and prevention
Zero TB declaration by activists

Activists stormed the stage at the World Health Organization (WHO) sponsored Stop TB Symposium during the 44th Union World Conference on Lung Health. TAG's TB Project Director Colleen Daniels called for global action and a new global attitude in the fight against TB.

Published
31 October 2013
From
Treatment Action Group
TB transmission and prevention
Gains in tuberculosis control at risk due to 3 million missed patients and drug resistance

Tuberculosis (TB) treatment has saved the lives of more than 22 million people, according to the WHO "Global tuberculosis report 2013" published today. The report also reveals that the number of people ill with TB fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.

Published
23 October 2013
From
World Health Organization (press release)
TB diagnosis
Plan to stop TB in kids overdue but problematic

Health officials are embarking on an ambitious plan to wipe out tuberculosis in children worldwide, even though they don't know exactly how many cases there are.

Published
02 October 2013
From
Yahoo! News
TB transmission and prevention
Tuberculosis genomes portray secrets of pathogen's success

The study, according to Pepperell, should help other researchers home in on genes that may be good candidates for targeting with new drugs, and aid disease control strategies that accommodate or even co-opt the bacterium's evolution and help drive its extinction.

Published
22 August 2013
From
Eurekalert Inf Dis
TB transmission and prevention
British tuberculosis rates among highest in Western Europe

Rates of tuberculosis (TB) in Britain are among the highest in western Europe and London is struggling to shed its status as the "TB capital" of the region, according to data released on Wednesday.

Published
21 August 2013
From
Reuters
TB transmission and prevention
Preventive Antibiotics for Tuberculosis Reduce Deaths Among People With HIV Disease

Study shows isoniazid therapy should be considered for millions of HIV-infected people globally .

Published
19 August 2013
From
Johns Hopkins Medicine
TB transmission and prevention
TB vaccine business case: lifesaving TB vaccines feasible

The global tuberculosis (TB) epidemic annually causes 1.4 million deaths and is estimated to cost the global economy €290 billion per year. Vaccines that could prevent people from acquiring, developing and transmitting disease would be the single most effective tool in mitigating this epidemic. Making new TB vaccines available to the world over the next 10-15 years is estimated to cost approximately €600 million, utilizing a highly efficient portfolio approach and adequate funding.

Published
12 June 2013
From
Tuberculosis Vaccine Initiative
← Prev1...23456...11Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.